Cellin Technologies in the press
January 21, 2015
Estonian company begins production of treatment to cure colorectal cancer
International Pharmaceutical Industry
Cellin Technologies LLC ‒ a GMP cell therapy products manufacturing company located in Tallinn, Estonia ‒ this week started production of melanoma cell lysate, the critical raw material required for the manufacture of MelCancerVac, the colorectal cancer vaccine developed by DanDrit Biotech.
January 15, 2015
Good terrorists trained in Tallinn lab
Postimees
In Mustamäe, Tallinn, training is provided to blood cells acquired from Italian cancer patients during clinical trials so that, when back home, these may point out intestine cancer cells to sick organisms – the latter thus able to fight these more effectively.
October 29, 2013
Breakthrough in stem cell surgery
Medlines
PARNU – Estonian doctors were preparing to present a real success story at a medical conference in Parnu last Friday – the first patient in Estonia in whose hand her own cell stems were implanted, restoring the mobility of her hand. This is a procedure which offers new possibilities for effective restoring of tissue in the future, reports Postimees.